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a b s t r a c t
Background: Opisthorchiasis is caused by an infection with ﬁsh-borne liver ﬂukes of the genus
Opisthorchis. Opisthorchiasis frequently leads to chronic inﬂammation in the biliary tract and is classiﬁed as a group 1 biological carcinogen by the International Agency for Research on Cancer: a deﬁnitive
risk for cholangiocarcinoma (CCA).
Methods: We used the rapid immunochromatographic test (ICT) to detect anti-Opisthorchis viverrini IgG
and IgG4 subclass antibodies in sera of patients with CCA. The ICT kits were developed based on soluble
antigens excreted and secreted by O. viverrini adult worms.
Results: ICT indicated sera was positive for IgG and IgG4 antibodies, respectively, in 22 (61.1%) and 15
(41.6%) participants of the 36 study participants diagnosed with CCA (P > 0.05). Our study also included
groups with other cancers and with liver cirrhosis, where the IgG ICT and IgG4 ICT kits were 27.7% (13/47)
and 25.5% (12/47) positive, respectively (P > 0.05). Neither total the IgG ICT nor the IgG4 ICT yielded
positive results in a control group of 20 healthy participants. Moreover, the percentage positivity rate
using the ICT for total IgG between the CCA group and the other cancers and liver cirrhosis group was
signiﬁcantly different (P < 0.05). By contrast, no signiﬁcant difference between these groups was apparent
in the ICT for IgG4 antibody. The CCA group was 6.53 times more likely to have positive anti–O. viverrini
IgG antibody (odds ratio 6.53, P < 0.001) and 3.27 times more likely to have positive anti–O. viverrini
IgG4 antibody (odds ratio 3.27, P = 0.010) than the non-CCA group.
Conclusion: This information is of potential value for the development of a diagnostic biomarker to predict risk for O. viverrini infection-associated CCA.
© 2021 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious
Diseases.
This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/)

Introduction
Cholangiocarcinoma (CCA) is a malignant neoplasm of the bile
duct. This cancer has been classiﬁed as either intrahepatic or
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extrahepatic, with the location in the second-order bile ducts
as the separating point. CCAs can be distinguished on the basis of their anatomic location along the biliary tree and categorized into the following three types depending on clinical presentation: intrahepatic CCA (iCCA), perihilar CCA (pCCA), and distal CCA (dCCA) (Blechacz et al., 2011; Deoliveira et al., 2011;
Waseem and Tushar, 2017). This malignancy is usually diﬃcult
to diagnose until it becomes advanced or disseminated and has
a poor prognosis with a 5-year survival rate of approximately
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5% for iCCA and 17% for pCCA and dCCA (Deng et al., 2021;
Squadroni et al., 2017). Prevalence varies greatly worldwide. The
northeastern provinces of Thailand have the highest prevalence
of CCA, with more than 80 cases per 10 0,0 0 0 people affected
(Banales et al., 2016; Kamsa-ard et al., 2018; Squadroni et al.,
2017). In regions where opisthorchiasis is endemic, including
the lower Mekong River subregion (i.e., Cambodia, Lao People’s
Democratic Republic, southern Vietnam, Myanmar, and Thailand)
(Sripa et al. 2010; Aung et al. 2017), more than 10 million people are estimated to be infected with O. viverrini. Infection results from the ingestion of raw or semicooked freshwater cyprinid
ﬁshes carrying the larval stage of the parasite called metacercaria. After ingestion, the motile juvenile ﬂuke excysts and enters the common bile through the ampulla of Vater and matures
to the adult form of liver ﬂuke in the intrahepatic bile ducts.
These parasites live in the biliary tract for several years, laying eggs, which in turn pass into the bile and eventually exit
the host through feces (Sripa et al. 2010). The risk factors for
opisthorchiasis-related CCA include chronic inﬂammation and attendant injury of the biliary epithelium due to persistent parasitism by the ﬂukes (Brindley et al., 2015, 2021). The high incidence of CCA in regions where liver ﬂuke occurs likely involves
risk factors unique to this tropical disease, primarily infection with
Opisthorchis viverrini, which is classiﬁed as a group 1 biological
carcinogen by the International Agency for Research on Cancer
(IARC, 2012; Khuntikeo et al., 2015; Sripa et al., 2011).
In a 2015 CCA screening project of 47,258 people residing in
the northeastern region of Thailand, 42.2% were infected with O.
viverrini due to the consumption of uncooked ﬁsh, and 29.9% were
diagnosed with CCA (Khuntikeo et al., 2015). Infection with this
helminth induces biological and chemical effects on host tissues–
promoters of DNA lesions, which result in chronic inﬂammation, ﬁbrosis, and other changes in microenvironment of the hepatobiliary
tract (Brindley and Loukas, 2017; Gouveia et al., 2017). One hypothesis suggests that reactive metabolites of oxysterol-like precursors
of O. viverrini and O. felineus are initiators of carcinogenesis, representing genotoxins that mutate genes of the epithelial cells that
line the bile ducts (Brindley et al., 2015; Gouveia et al., 2017).
Stool examination to detect eggs in feces is the gold standard
for the diagnosis of O. viverrini infection. This technique can diagnose patients with heavy active infection, but false negatives occur
in latent infections with low worm burdens or biliary obstruction
(Phupiewkham et al., 2021; Sawangsoda et al., 2012). Serodiagnosis
for opisthorchiasis also can provide sensitive and speciﬁc diagnosis (Phupiewkham et al., 2021; Sadaow et al., 2019; Tesana et al.,
2007). Serum immunoglobulin G (IgG) antibody against antigens
in lysates of adult worms and of metacercariae can persist in infected hosts after parasitologic cure (Akai et al., 1995). Moreover,
the immunoglobulin G4 subclass (IgG4) antibody is useful and speciﬁc for diagnosis of opisthorchiasis (Phupiewkham et al., 2021;
Tesana et al., 2007). It is noteworthy that serum titers of anti–O.
viverrini antibodies have been found to be higher in cases of CCA
than in cases of cholangitis caused by O. viverrini or in the absence
of infection (Akai et al., 1994; Itoh et al., 1994). Accordingly, serum
IgG and IgG4 antibodies can be of value not only for the detection of O. viverrini infection but also in screening for O. viverrini–
associated CCA.
Recently, Sadaow et al. (2019) developed the rapid diagnostic
immunochromatographic test (ICT) as a point-of-care (POC) testing
tool for IgG antibody detection, which can be used at the bedside
without the need for sophisticated equipment. Here, we tested this
ICT for the detection of anti–O. viverrini IgG and IgG4 subclass antibodies in the serum of study participants with CCA. Our present
ﬁndings conﬁrm that this ICT may be able to augment the diagnosis of liver ﬂuke infection by stool examination. It also may be useful to increase prediction and awareness of the new O. viverrini–

associated CCA cases in at-risk populations and to reduce the costs
of screening, thereby enabling better planning both to reduce risk
and also increase survival outcomes for opisthorchiasis-associated
CCA.
Materials and methods
Sera
A total of 103 serum samples from the Frozen Serum Bank at
the Faculty of Medicine, Khon Kaen University were included in
this study. These sera were assigned to three groups as follows:
group I, CCA group (n = 36); group II, other cancers and liver cirrhosis group (n = 47) including hepatocellular carcinoma (n = 28),
liver cirrhosis (n = 4), colorectal cancer (n = 8), and brain cancer (n = 7); and group III, other healthy individuals (n = 20). Persons who donated the sera in this latter control group were free
of malignancies and also free of intestinal parasites as ascertained
by parasitologic methods (Elkins et al., 1986) at the time of phlebotomy. Demographic data are provided in Table 1. The residual
sera, investigated here, were obtained from each participant in this
study before surgery at Srinagarind Hospital, Khon Kaen University.
Detection of immunoglobulin G by rapid diagnostic ICT
The opisthorchiasis and clonorchiasis diagnostic ICT kit using O.
viverrini excretory-secretory (ES) antigen (Sadaow et al., 2019) was
used for screening of IgG antibody against O. viverrini in human
serum samples. The ICT kit was used as described (Sadaow et al.,
2019). Brieﬂy, 5 μL of diluted serum (1:30) was dispensed into the
sample well, followed by 90 μL of running buffer. The assay result
was read at 15 minutes after the addition of the running buffer;
if red bands appeared at both test and control lines, serum was
considered to be positive, whereas if a red band appeared only at
the control line, serum was considered to be negative. The intensity of the bands was scored visually by comparison with the reference card. A band intensity ≥ 0.5 was conﬁrmed to be positive
(Sadaow et al., 2019).
Detection of IgG4 subclass antibody by rapid diagnostic ICT
For the detection of serum IgG4 antibody against O. viverrini,
the newly developed ICT strip under optimal condition was used
as described (Sadaow et al., 2019) with some modiﬁcation. Brieﬂy,
2 mg/mL of O. viverrini ES antigen (Intapan and Maleewong, 2006;
Sadaow et al., 2019) and 2 mg/mL of anti-mouse IgG (Lampire Biological Laboratories, Pipersville, Pennsylvania) were dispensed onto
nitrocellulose membrane (Sartorius Stedim Biotech SA, Goettingen,
Germany), at a ﬂow rate of 0.1 μL/mm, to serve as the test and
control lines, respectively. Six micrograms per milliliter of mouse
anti-human IgG4 (Invitrogen, Eugene, Oregon) conjugated with colloidal gold (Kestrel BioSciences Co., Pathumthani, Thailand) was
sprayed onto a glass microﬁber ﬁlter GF33 (conjugate pad) (Whatman Schleicher & Schuell, Dassel, Germany). For testing, 5 μL of
undiluted serum samples was added to a sample well, followed by
100-μL running buffer. The assay result was read at 15 minutes
after the addition of the running buffer by visual examination: the
intensity of the band was scored visually by comparison with the
reference card. A band intensity ≥ 0.5 was considered to be positive.
Statistical analysis
The Shapiro-Wilk test was used to assess data normality. Pearson chi-square test was used to investigate the associations between categorical variables between groups. The correlations be81
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Table 1
Demographic and baseline characteristics of the study participants.
Characteristics
Gender
Male, n (%)
Female, n (%)
Age (year)
≤ 40, n (%)
41-50, n (%)
51-60, n (%)
>60, n (%)
Mean ± SD (range)
Location of CCA tumorb
Distal, n (%)
Intrahepatic, n (%)
Perihilar, n (%)
Mixed location, n (%)
Gross pathology of CCA
Intraductal growth, n (%)
Mass-forming type, n (%)
Periductal inﬁltrating, n (%)
a
b

CCA (n = 36)

Other cancers and liver cirrhosis (n = 47)

Healthy control (n = 20)

24 (66.7)
12 (33.3)

34 (72.3)
13 (27.7)

11 (55.0)
9 (45.0)

2 (5.6)
1 (2.8)
16 (44.4)
17 (47.2)
59.7 ± 9.8 (32-77)

6 (12.8)
5 (10.6)
12 (25.5)
24 (51.1)
56.7 ± 15.0 (15-79)

4 (20.0)
4 (20.0)
6 (30.0)
6 (30.0)
50.1 ± 12.9 (27-65)

P valuea
0.385

0.122

4 (11.1)
17 (47.2)
14 (38.9)
1 (2.8)
9 (25.0)
14 (38.9)
13 (36.1)

P value for test of difference between-group was compared using Pearson’s chi-squared test.
Anatomic locations of CCA were differentiated as described (Blechacz et al., 2011).
Table 2
Reactive frequencies of Opisthorchis viverrini antibody using total IgG ICT and IgG4 ICT.

Cholangiocarcinoma
Overall (n = 36)
Distal (n = 4)
Intrahepatic (n = 17)
Perihilar (n = 14)
Mix (n = 1)
Other cancers and liver cirrhosis
Overall (n = 47)
Hepatocellular carcinoma (n = 28)
Liver cirrhosis (n = 4)
Colorectal cancer (n = 8)
Brain cancer (n = 7)
a

Number of positive cases (%)
IgG ICT

P valuea
IgG4 ICT

22 (61.1)
3 (75.0)
10 (58.8)
8 (57.1)
1 (100.0)

15 (41.6)
2 (50.0)
5 (29.4)
7 (50.0)
1 (100.0)

0.092

13 (27.7)
9 (32.1)
0 (0)
3 (37.5)
1 (14.3)

12 (25.5)
11 (39.3)
0 (0)
1 (12.5)
0 (0)

1.000

Exact McNemar signiﬁcance probability

tween results of IgG and IgG4 ICT kits were tested using the McNemar test statistic. The odds ratios with their 95% conﬁdence interval (CI) and P value were obtained using logistic regression. A
P value ≤ 0.05 was considered statistically signiﬁcant. Statistical
analyses were performed by using STATA version 10.1 (Stata Corp,
College Station, Texas).

0.05) in the IgG4 antibody detection (Figure 1). In regression analyses, the CCA group was signiﬁcantly more likely to include total IgG antibody (odds ratio 6.53, P ≤ 0.001) and more likely to
include IgG4 antibody (odds ratio 3.27, P = 0.010) than the nonCCA groups (i.e., the other cancers and liver cirrhosis group and
the healthy control group) (Table 3).

Results

Discussion

We used the ICT kits for detection of anti–O. viverrini IgG and
anti–O. viverrini IgG4 antibodies. For 36 CCA samples, the IgG ICT
kit showed a positivity of 61.6% in 22 cases and positivity by IgG4
ICT kit in 15 cases (41.6%) (P value > 0.05) (Table 2). For 47 other
cancers and liver cirrhosis samples, the IgG ICT showed a positivity
in 13 cases (27.7%) and the IgG4 ICT showed 25.5% (12 participants)
positivity (P value > 0.05) (Table 2). Positivity of CCA samples in
both IgG and IgG4 ICT kits was 12 of 36 cases (33.3%), whereas
only 10 (27.8%) and 3 (8.3%) cases were positive with IgG ICT and
IgG4 ICT kits, respectively. When the positive results of both methods were combined, the sensitivity increased to 69.4% (25/36). Of
47 cases, 8 samples (17%) from the other cancers and liver cirrhosis
group were positive in both IgG and IgG4 ICT kits (Supplementary
Table 1). Neither IgG ICT nor IgG4 ICT yielded positive results in
the 20 healthy controls or in 4 liver cirrhosis cases. The number of
IgG antibody–positive sera was signiﬁcantly different between the
CCA group and the other cancers and liver cirrhosis group (P value
< 0.05). However, there was no signiﬁcant difference (P value >

Whereas the detection of the eggs of O. viverrini in the stool is
the gold standard for the diagnosis of opisthorchiasis, detection of
O. viverrini eggs in stool samples can be hampered by obstructive
jaundice during CCA. Thus, several reports have established that in
the setting of active O. viverrini infection during CCA, the fecal O.
viverrini egg count and estimated incidence of CCA was only poorly
correlated (Sriamporn et al., 2004; Srivatanakul et al., 1991). Likewise, fecal egg numbers may only be weakly correlated with antibody (Phupiewkham et al., 2021). Nonetheless, other studies in
Thailand have revealed that the levels of speciﬁc anti–O. viverrini
antibodies in human sera as examined by ELISA and the incidence
of CCA were positively correlated (Akai et al., 1994; Itoh et al.,
1994). Within this context, our present study focused on the examination of IgG and IgG4 antibodies against O. viverrini in serum
during CCA by using rapid POC diagnostic ICT kits.
For the CCA group, anti-IgG O. viverrini antibody revealed a positivity rate of 61.1%, which was in line with previous ﬁndings for
CCA sera that used anti-IgG antibody against somatic antigens of
82
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Figure 1. Rates of positive detection of anti–O. viverrini IgG (A) and IgG4 antibodies (B) with the total IgG ICT and IgG4 ICT kits. Statistically signiﬁcant differences between
CCA, other cancer and liver cirrhosis, and healthy control groups are indicated by asterisks: ∗ ∗ ∗ P ≤ 0.001; ∗ ∗ P ≤ 0.01; ns, not signiﬁcant. CCA, cholangiocarcinoma sera
(n = 36); Other cancers, other cancers and liver cirrhosis sera (n = 47); HC, healthy control sera (n = 20); Pearson chi-square test.
Table 3
The statistical analysis showing the odds ratios and 95% conﬁdence interval among the CCA group, other cancers and
liver cirrhosis group, and the healthy control group.
Odds ratio
IgG (95% CI)
CCA vs other cancers and liver cirrhosis (n = 83)
CCA vs non-CCAa (n = 103)
a
∗

4.11 (1.63-10.37)
6.53 (2.66-16.10)

P value
∗

0.002
<0.001∗

IgG4 (95% CI)

P value

2.08 (0.82-5.29)
3.27 (1.32-8.14)

0.121
0.010∗

Value calculation when combining non-CCA (other cancers and liver cirrhosis and healthy control) groups.
Statistically signiﬁcant difference, P ≤ 0.05

adult O. viverrini ﬂukes (Itoh et al., 1994; Titapun et al., 2020). The
detection rate for parasite-speciﬁc anti-IgG4 antibody was lower
(41.6% positivity). This outcome conforms with our recent ﬁndings
for residents in an opisthorchiasis-endemic region of rural Khammouane Province in central Lao PDR, which suggests that this antiIgG–based test performs better than the anti–O. viverrini IgG4 detection for the diagnosis of ﬂuke infection (Phupiewkham et al.,
2021). Interestingly, when considering the combined ﬁndings of
both methods, the sensitivity of antibody detection increased to
69.4% (25/36), and hence, both biomarkers can be used to expand
capacity screening to predict risk of opisthorchiasis-related CCA.
It is notable that about 1 in 4 participants in the group that
includes other cancers and liver cirrhosis was positive for anti–
O. viverrini IgG (27.7%) and IgG4 (25.5%) antibodies, whereas more
than a third of the participants from the hepatocellular carcinoma group was seropositive for anti–O. viverrini ES IgG4 antibody
(39.3%). The parsimonious interpretation of these ﬁndings was that
these seropositive results reﬂected historical exposure to infection,
given that these participants lived in the opisthorchiasis-endemic
region of Thailand.
These ﬁndings also revealed a signiﬁcant positive association
between CCA and anti–O. viverrini IgG antibody. Thus, there was
a greater likelihood of O. viverrini antibody using IgG ICT and IgG4
ICT kits in the participants with CCA than in participants without
CCA, which conforms with the earlier reports (Itoh et al., 1994).
Additional support was shown by the presence of anti–O. viverrini
IgG antibody and the expression of growth factor receptor (HER2
protein) associated with poorer prognosis of CCA (Titapun et al.,
2020). Opisthorchiasis is a deﬁnitive risk for CCA; in addition to
the application of guidelines of the Thai National Health Control Program and the Cholangiocarcinoma Screening and Care Program (Khuntikeo et al., 2015, 2016,), serodiagnosis can also pro-

vide sensitive alternative techniques for the detection of this infection (Akai et al., 1994; Itoh et al., 1994; Sadaow et al., 2019;
Tesana et al., 2007; Titapun et al., 2020).
In conclusion, these new ﬁndingshighlighted the diagnostic potential of a rapid ICT platform that uses ES products from O.
viverrini ﬂukes for serodiagnosis of opisthorchiasis-associated CCA.
People living in areas endemic for opisthorchiasis can be rapidly
screened for liver ﬂuke infection using the rapid IgG ICT and IgG4
ICT kits, including where infections may be asymptomatic or mild,
and where there are complications that can include hepatobiliary morbidity involving hepatomegaly, cholangitis, cholecystitis,
periductal ﬁbrosis, and/or gallstones along with a stool examination that is negative for Opisthorchis eggs (Phupiewkham et al.,
2021; Sawangsoda et al., 2012). The information is of note with
respect to prognostic and diagnostic biomarkers for screening for
those at risk of developing CCA in regions endemic for liver ﬂuke
infection and for disease prevention. However, other associations
and factors including dietary nitrosamines, interactions or changes
in the gastrointestinal and biliary microbiota, primary sclerosing
cholangitis, inﬂammatory bowel disease, metabolic syndromes, viral hepatitis, and carriage of species of Helicobacter also need to be
considered (Brindley et al., 2015).
Author contributions
Conceptualization and design: RR, VL, WS, AK, KP, WI, VHM,
PMI, PJB, and WM. Methodology: RR, VL, LS, WS, AK, KP, OS, PMI,
and PJB. Formal analysis and investigation: RR, VL, LS, WS, AK, KP,
OS, PMI, and WM. Writing-original draft preparation: RR, VL, WI,
and VHM. Writing-review and editing: RR, WI, PJB, PMI, and WM.
Supervision: WM, VHM, PJB, and PMI. All authors read and approved the ﬁnal manuscript.
83

R. Rodpai, V. Luvira, L. Sadaow et al.

International Journal of Infectious Diseases 116 (2022) 80–84

Ethics

Deoliveira ML, Schulick RD, Nimura Y, Rosen C, Gores G, Neuhaus P, et al. New
staging system and a registry for perihilar cholangiocarcinoma. Hepatology
2011;53:1363–71. doi:10.1002/hep.24227.
Elkins DB, Haswell-Elkins M, Anderson RM. The epidemiology and control of intestinal helminths in the Pulicat Lake region of Southern India. I. Study design and
pre- and post-treatment observations on Ascaris lumbricoides infection. Trans R
Soc Trop Med Hyg 1986;80:774–92. doi:10.1016/0035-9203(86)90384-6.
Gouveia MJ, Pakharukova MY, Laha T, Sripa B, Maksimova GA, Rinaldi G,
et al. Infection with Opisthorchis felineus induces intraepithelial neoplasia of the biliary tract in a rodent model. Carcinogenesis 2017;38:929–37.
doi:10.1093/carcin/bgx042.
IARC. Working Group on the Evaluation of Carcinogenic Risks to Humans. Biological agents. Volume 100B. A review of human carcinogens. IARC Monogr Eval
Carcinog Risks Hum 2012;100(Pt B):1–441.
Intapan PM, Maleewong W. Opisthorchis viverrini: inﬂuence of maternal infection in
hamsters on offspring infected with homologous parasite and their IgG antibody
response. Exp Parasitol 2006;113:67–74. doi:10.1016/j.exppara.2005.12.008.
Itoh M, Pairojkul C, Thamawit W, Sithithaworn P, Tiwawech D, Uttaravicien T,
et al. Association of antibodies to Opisthorchis viverrini with hepatobiliary disease in Northeastern Thailand. Am J Trop Med Hyg 1994;51:424–9.
doi:10.4269/ajtmh.1994.51.424.
Kamsa-ard S, Kamsa-ard S, Luvira V, Suwanrungruang K, Vatanasapt P,
Wiangnon S. Risk factors for cholangiocarcinoma in Thailand: A systematic review and meta-analysis. Asian Pac J Cancer Prev 2018;19:605–14.
doi:10.22034/APJCP.2018.19.3.605.
Khuntikeo N, Chamadol N, Yongvanit P, Loilome W, Namwat N, Sithithaworn P, et al.
Cohort proﬁle: cholangiocarcinoma screening and care program (CASCAP). BMC
Cancer 2015;15:459. doi:10.1186/s12885-015-1475-7.
Khuntikeo N, Loilome W, Thinkhamrop B, Chamadol N, Yongvanit P. A comprehensive public health conceptual framework and strategy to effectively combat cholangiocarcinoma in Thailand. PLoS Negl Trop Dis 2016;10.
doi:10.1371/journal.pntd.0 0 04293.
Phupiewkham W, Rodpai R, Inthavongsack S, Laymanivong S, Thanchomnang T,
Sadaow L, et al. High prevalence of opisthorchiasis in rural populations
from Khammouane Province, central Lao PDR: serological screening using total IgG- and IgG4-based ELISA. Trans R Soc Trop Med Hyg 2021:trab066.
doi:10.1093/trstmh/trab066.
Sadaow L, Sanpool O, Rodpai R, Yamasaki H, Ittiprasert W, Mann VH, et al. Development of an immunochromatographic point-of-care test for serodiagnosis
of opisthorchiasis and clonorchiasis. Am J Trop Med Hyg 2019;101:1156–60.
doi:10.4269/ajtmh.19-0446.
Sawangsoda P, Sithithaworn J, Tesana S, Pinlaor S, Boonmars T, Mairiang E, et al.
Diagnostic values of parasite-speciﬁc antibody detections in saliva and urine
in comparison with serum in opisthorchiasis. Parasitol Int 2012;61:196–202.
doi:10.1016/j.parint.2011.06.009.
Squadroni M, Tondulli L, Gatta G, Mosconi S, Beretta G, Labianca R.
Cholangiocarcinoma.
Crit
Rev
Oncol
Hematol
2017;116:11–31.
doi:10.1016/j.critrevonc.2016.11.012.
Sriamporn S, Pisani P, Pipitgool V, Suwanrungruang K, Kamsa-ard S, Parkin DM.
Prevalence of Opisthorchis viverrini infection and incidence of cholangiocarcinoma in Khon Kaen, Northeast Thailand. Trop Med Int Health 2004;9:588–94.
doi:10.1111/j.1365-3156.2004.01234.x.
Sripa B, Bethony JM, Sithithaworn P, Kaewkes S, Mairiang E, Loukas A, et al.
Opisthorchiasis and opisthorchis-associated cholangiocarcinoma in Thailand and
Laos. Acta Tropica 2011;120:S158–68. doi:10.1016/j.actatropica.2010.07.006.
Sripa B, Kaewkes S, Intapan PM, Maleewong W, Brindley PJ. Food-borne trematodiases in Southeast Asia epidemiology, pathology, clinical manifestation and control. Adv Parasitol 2010;72:305–50. doi:10.1016/S0065-308X(10)72011-X.
Srivatanakul P, Parkin DM, Jiang YZ, Khlat M, Kao-Ian UT, Sontipong S, et al. The role of infection by Opisthorchis viverrini, hepatitis B virus, and aﬂatoxin exposure in the etiology of liver
cancer in Thailand. A correlation study. Cancer 1991;68:2411–17
10.1002/1097-0142(19911201)68:11<2411::aid-cncr2820681114>3.0.co;2-0,
11<2411::aid-cncr2820681114>3.0.co;2-0.
Tesana S, Srisawangwong T, Sithithaworn P, Itoh M, Phumchaiyothin R. The ELISAbased detection of anti- Opisthorchis viverrini IgG and IgG4 in samples of human
urine and serum from an endemic area of north–eastern Thailand. Ann Trop
Med Parasitol 2007;101:585–91. doi:10.1179/136485907X229068.
Titapun A, Techasen A, Sa-Ngiamwibool P, Sithithaworn P, Luvira V, Srisuk T,
et al. Serum IgG as a marker for Opisthorchis viverrini-associated cholangiocarcinoma correlated with HER2 overexpression. Int J Gen Med 2020;13:1271–83.
doi:10.2147/IJGM.S282519.
Waseem D, Tushar P. Intrahepatic, perihilar and distal cholangiocarcinoma: management and outcomes. Ann Hepatol 2017;16:133–9.
doi:10.5604/16652681.1226927.

This study was approved by the research ethics committee of
the Khon Kaen University Ethics Committee for Human Research
(Ethics number: HE641114, approved June 7, 2021).
Funding
This study was supported by Distinguished Research Professor Grant, Thailand Research Fund (TRF) [PMI and WM, grant
no. DPG 6280 0 02]; Khon Kaen University, Research and Graduate
Studies Affairs [OS, PMI, and WM, Research Program]; Faculty of
Medicine, Khon Kaen University [PMI and WM, grant no. DR63101
and RG63301]; a scholarship under the Post-Doctoral Training Program from Khon Kaen University (KKU) [RR, grant no. PD256409]; and the National Cancer Institute, National Institutes of Health
(NIH), USA [PJB and PMI, award no. RO1CA164719]. The contents of
this report are solely the responsibility of the authors and do not
necessarily represent the oﬃcial views of the TRF, KKU, or the NIH.
Conﬂicts of interest
The authors declare that they have no conﬂicts of interest.
Acknowledgments
We express our gratitude to Jitaporn Harasan from the Mekong
Health Science Research Institute for provision of expert immunochromatographic technique.
Supplementary materials
Supplementary material associated with this article can be
found, in the online version, at doi:10.1016/j.ijid.2021.12.347.
References
Akai PS, Pungpak S, Chaicumpa W, Kitikoon V, Ruangkunaporn Y, Bunnag D, et al.
Serum antibody responses in opisthorchiasis. Int J Parasitol 1995;25:971–3.
doi:10.1016/0 020-7519(94)0 0212-7.
Akai PS, Pungpak S, Chaicumpa W, Viroj K, Bunnag D, Befus AD. Serum antibody response to Opisthorchis viverrini antigen as a marker for opisthorchiasisassociated cholangiocarcinoma. Trans R Soc Trop Med Hyg 1994;88:471–4.
doi:10.1016/0035-9203(94)90438-3.
Aung WPP, Htoon TT, Tin HH, Thinn KK, Sanpool O, Jongthawin J, et al.
First report and molecular identiﬁcation of Opisthorchis viverrini infection in human communities from Lower Myanmar. PLoS One 2017;12(5).
doi:10.1371/journal.pone.0177130.
Banales JM, Cardinale V, Carpino G, Marzioni M, Andersen JB, Invernizzi P, et al. Expert consensus document: Cholangiocarcinoma: current knowledge and future
perspectives consensus statement from the European Network for the Study of
Cholangiocarcinoma (ENS-CCA). Nat Rev Gastroenterol Hepatol 2016;13:261–80.
doi:10.1038/nrgastro.2016.51.
Blechacz B, Komuta M, Roskams T, Gores GJ. Clinical diagnosis and staging of cholangiocarcinoma. Nat Rev Gastroenterol Hepatol 2011;8:512–22.
doi:10.1038/nrgastro.2011.131.
Brindley PJ, da Costa JMC, Sripa B. Why does infection with some helminths cause
cancer? Trends Cancer 2015;1:174–82. doi:10.1016/j.trecan.2015.08.011.
Brindley PJ, Loukas A. Helminth infection-induced malignancy. PLoS Pathog 2017;13.
doi:10.1371/journal.ppat.1006393.
Brindley PJ, Bachini M, Ilyas SI, Khan SA, Loukas A, Sirica AE, et al. Cholangiocarcinoma. Nat Rev Dis Primers 2021;7(1):65. doi:10.1038/s41572-021-0 030 0-2.
Deng X, Zuo M, Pei Z, Xie Y, Yang Z, Zhang Z, et al. MicroRNA-455-5p contributes to
cholangiocarcinoma growth and mediates Galangin’s anti-tumor effects. J Cancer 2021;12:4710–21. doi:10.7150/jca.58873.

84

